Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Platelet crossmatch testing for donor selection

S J Slichter

    Progress in Clinical and Biological Research
    |January 1, 1982
    PubMed
    Summary
    This summary is machine-generated.

    Platelet crossmatch tests improve donor selection for patients needing platelet transfusions. These tests offer higher predictability than lymphocytotoxic tests, ensuring better post-transfusion responses for refractory thrombocytopenic patients.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Clinical and laboratory correlates of platelet alloimmunization and refractoriness in the PLADO trial.

    Vox sanguinis·2016
    Same author

    Further studies to evaluate methods of leucoreduction to prevent alloimmune platelet refractoriness and induce tolerance in a dog platelet transfusion model.

    Vox sanguinis·2016
    Same author

    Extended storage of autologous apheresis platelets in plasma.

    Vox sanguinis·2013
    Same author

    Platelet transfusion: future directions.

    Vox sanguinis·2004
    Same author

    Prophylactic platelet transfusions from healthy apheresis platelet donors undergoing treatment with thrombopoietin.

    Blood·2001
    Same author

    Universal WBC reduction.

    Transfusion·2000
    Same journal

    DNA homology and chromosome stability: a sensitive yeast genetic system for identifying double-stranded DNA damage.

    Progress in clinical and biological research·2018
    Same journal

    Endotoxin and sepsis: molecular mechanisms of pathogenesis, host resistance, and therapy. Proceedings of the 4th Conference of the International Endotoxin Society. Nagoya, Japan, October 23-27, 1996.

    Progress in clinical and biological research·1998
    Same journal

    The pathogenic role of LBP in gram-negative sepsis and septic shock.

    Progress in clinical and biological research·1998
    Same journal

    The role of interleukin 6 in endotoxin-induced inflammatory responses.

    Progress in clinical and biological research·1998
    Same journal

    Role of nitric oxide and reactive oxygen species in endotoxin shock.

    Progress in clinical and biological research·1998
    Same journal

    Interaction of lipopolysaccharide with a mammalian lyso-phosphatidate acyltransferase (LPAAT) transfected into E. coli, and effect of lisofylline on LPAAT transfected into mammalian cells.

    Progress in clinical and biological research·1998
    See all related articles

    Area of Science:

    • Hematology
    • Immunology
    • Transfusion Medicine

    Background:

    • Alloimmunized refractory thrombocytopenic patients often show poor responses to HLA-compatible platelet transfusions.
    • HLA-incompatible transfusions can sometimes yield satisfactory platelet increments.

    Purpose of the Study:

    • To enhance the selection process for compatible platelet donors in challenging patient cases.
    • To evaluate the efficacy of different crossmatch tests in predicting transfusion success.

    Main Methods:

    • Comparison of lymphocytotoxic crossmatch tests with platelet crossmatch tests.
    • Analysis of predictability rates for both crossmatch methodologies.

    Main Results:

    • Lymphocytotoxic crossmatch tests demonstrate only 65% predictability with frequent false negatives.

    Related Experiment Videos

  • Platelet crossmatch tests show significantly higher predictability, ranging from 84% to 93% in reported studies.
  • Conclusions:

    • Platelet crossmatch tests are more reliable for selecting compatible platelet donors.
    • Given the risks and resource intensity of apheresis, platelet crossmatch tests are crucial for improving patient outcomes and donor selection efficiency.